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The major structural proteins of porcine reproductive and respiratory syndrome virus (PRRSV) are derived from ORFs 5,
6, and 7. Western blots of sucrose gradient-purified virions and PRRSV-infected MARC-145 cells, probed with immune pig
serum, showed the presence of an additional 10-kDa protein. Nucleotide sequence analysis of North American PRRSV isolate
SDSU-23983 revealed a small ORF within ORF2, named ORF2b, which, when translated, produced a 73-amino-acid
nonglycosylated protein. Recombinant 2b protein expressed by a baculovirus clone, AcVR2, comigrated with the 10-kDa
virus-associated protein. The loss of 10-kDa protein immunoreactivity after absorption of immune sera with lysates from
AcVR2-infected insect cells demonstrated that the 2b and 10-kDa proteins are immunologically similar. Immunoblots were
also used for the detection of anti-2b activity in serum samples from experimentally infected adult pigs. Antibodies against
PRRSV were apparent by 14 days postinfection, followed by anti-2b activity and serum neutralizing activity. The putative
ORF2b start codon is only 6 nucleotides downstream of the adenine of the ORF2a start codon. The expression of ORF2a and
2b as enhanced green fluorescent fusion proteins showed that both proteins were translated; however, the ORF2b was
preferentially expressed. These results suggest that the 2b protein is virion associated and the principal product of ORF2.
© 2001 Academic Press
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Porcine reproductive and respiratory syndrome virus
(PRRSV), a member of the family Arteriviridae, causes
reproductive disorders in breeding stock and severe
respiratory disease in neonates (see Rossow, 1998, for
review). Currently, PRRSV isolates are divided into two
distinct groups, represented by Lelystad virus in Europe
(Wensvoort et al., 1991) and VR-2332 in the United States
(Benfield et al., 1992) and Canada (Dea et al., 1992). Even
though European and North American isolates possess
several biological and immunological similarities, includ-
ing a nearly identical genome organization, both strains
are genetically and antigenically distinct (Mardassi et al.,
1994; Magar et al., 1995; Nelsen et al., 1999). Other
members of the arterivirus family include lactate dehy-
drogenase-elevating virus (LDV) of mice, equine arteritis
virus (EAV), and simian hemorrhagic fever virus (for re-
view see Plagemann, 1996; Snijder and Meulenberg,
1998). Along with Coronaviridae, the arteriviruses are
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Veterinary Science, Box 2175, South
akota State University, Brookings, SD 57007. Fax: 606-688-6003.
-mail: Eric_Nelson@sdstate.edu.183placed in a relatively new order, Nidovirales (Cavanagh,
1997).
PRRSV is an enveloped, positive-polarity, nonseg-
mented, single-stranded RNA virus possessing a 15-kb
genome containing 7 ORFs. The principal nonstructural
proteins, encoded by ORFS 1a and 1b, have replicase
and helicase activities. The PRRS virion contains three
major structural proteins, GP5, M, and N, encoded by
ORFs 5, 6, and 7, respectively. The 15-kDa N protein
forms the principal component of the nucleocapsid and
localizes to the host cell nucleolus during replication
(Rowland et al., 1999a). The envelope matrix protein, M,
is disulfide bonded to the major envelope glycoprotein,
GP5 (Faaberg et al., 1995; Mardassi et al., 1996; Plage-
mann, 1996; Snijder and Muelenberg, 1998). The prod-
ucts of ORFs 2, 3, and 4 (GP2, GP3, and GP4, respec-
tively) may represent additional components of the PRRS
virion (Meulenberg et al., 1997; Meulenberg and Pe-
tersen-den Besten, 1996; van Nieuwstadt et al., 1996;
Gonin et al., 1998).
ORF2 of VR-2332, the prototypic North American
PRRSV isolate, encodes a 256-amino-acid glycoprotein
with a predicted molecular mass of 24 kDa (Murtaugh et
al., 1995). However, only small amounts of GP2 are im-
munoprecipitated from virions and infected cells (Meu-0042-6822/01 $35.00
Copyright © 2001 by Academic Press
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184 WU ET AL.lenberg et al., 1995; Meulenberg and Petersen-den
Besten, 1996; Dea et al., 2000). Recently, Snijder et al.
(1999) reported a new structural protein in EAV, a product
of the bicistronic expression of ORF2 and named E. The
start codon for E is located 72 nucleotides upstream and
codes for a relatively small 67-amino-acid, nonglycosy-
lated protein possessing a predicted single transmem-
brane domain. Reverse genetics, using an infectious
clone, demonstrated that the E protein is required for the
production of infectious virions. An ORF similar to the
EAV E gene, labeled ORF2b in European PRRSV, is found
embedded within the larger ORF2a and, when translated,
codes for a 70-amino-acid, nonglycosylated protein pos-
sessing a predicted single transmembrane domain. The
start codon for PRRSV ORF2b is located only 6 nucleo-
tides downstream of the larger ORF2a start codon
(Snijder et al., 1999). In this paper we report the presence
of a 10-kDa protein in the virion of a North American
PRRSV isolate and identify its source as ORF2b.
RESULTS AND DISCUSSION
The 8-kDa E protein in EAV is virion-associated and
required for the production of infectious virus (Snijder et
al., 1999). Therefore, our first experiments were designed
to identify the presence of a similar protein in prepara-
tions containing purified PRRS virions. The North Amer-
ican PRRSV isolate SDSU-23983 was sucrose gradient-
purified and viral proteins were separated by SDS–PAGE
on a 17% acrylamide gel. Viral proteins in individual
fractions were visualized in immunoblots using pooled
immune sera obtained from infected pigs that possessed
high PRRSV-specific titers and high specific reactivity to
GP5, the major viral envelope glycoprotein. Representa-
tive Western blot results, presented in Fig. 1A, showed
the presence of a small protein of approximately 10 kDa
that migrated well below the 15-kDa nucleocapsid pro-
tein. In this particular experiment, the 10-kDa protein was
prominent in sucrose gradient fractions 11 and 12, which
also contained the largest quantities of N (15 kDa), M (19
kDa), and GP5 (25–30 kDa) viral proteins. Refractometry
measurements identified the densities of fractions 11
and 12 as 1.14 and 1.16 g/cm3, respectively (see Fig. 1B),
hich is consistent with the density of PRRSV (Benfield
t al., 1992; Bautista et al., 1996). A 10-kDa protein was
ot detected in Western blots of mock-infected cells
ncubated with immune sera or infected cells incubated
ith sera from PRRSV-negative pigs (data not shown).
e also followed the accumulation of the 10-kDa protein
uring infection of MARC-145 cells. In cultures infected
ith 0.1 m.o.i. of PRRSV, detectable amounts of the 10-
Da protein appeared by 15 h after infection, about 6 h
fter the first appearance of GP5, M, and N (Fig. 2).
verexposure of Western blots showed detectable
mounts of the 10-kDa protein as early as 9 h afternfection (data not shown). cThe expression of EAV E and Gs proteins is the result
f the bicistronic expression of mRNA 2 and the individ-
al ORFs designated ORF2a and ORF2b, respectively.
he start codon for EAV ORF2a is located upstream of
he initiation site for the larger ORF2b. An ORF similar to
is found in European PRRSV, except the putative start
odon is located 6 nucleotides downstream of the AUG
f ORF2a (the A in AUG as 11) and was, therefore,
esignated ORF2b (Snijder et al., 1999). Analysis of the
RF2 region of the North American isolate, SDSU-23983,
evealed a small ORF that, similar to European PRRSV,
tarted 6 nucleotides downstream of the ORF2a start
odon (Fig. 3A). Translation of this ORF produces a
rotein that is predicted to be 73 amino acids in length.
omparison of SDSU-23983 with Lelystad virus showed
hat both 2b proteins had a 74% identity at the amino acid
evel with perfect matches at 52 amino acid positions
Fig. 3B) and possessed conserved myristoylation and
K-II phosphorylation sites. Furthermore, CLUSTAL anal-
sis identified 12 of the amino acid differences as being
FIG. 1. Identification of a 10-kDa protein in PRRSV. Medium from
MARC-145 cells infected with SDSU-23983 was fractionated on a su-
crose gradient. (A) Individual fractions were electrophoresed on a 17%
acrylamide gel and then transferred to nitrocellulose. PRRSV proteins
were identified with a pooled preparation of immune pig sera as
described under Materials and Methods. Molecular size markers, in
kDa, are on the right. (B) Refractive index and density measurements of
individual fractions.onserved changes. This degree of identity is remark-
185ORF2b PROTEIN OF PRRSVable considering that the amino acid similarities be-
tween the North American isolate VR-2332 and European
Lelystad viruses range between 55% for the ORF5 pro-
tein, GP5, and 79% for the ORF6 matrix protein. The only
significant difference is that SDSU-23983 is predicted to
be 3 amino acids longer than the 70-amino-acid Euro-
pean PRRSV 2b protein. Interestingly, SDSU-23983 pos-
sesses a second potential start codon, located 9 nucle-
otides downstream of the predicted ORF2b AUG. It is
unlikely that this second AUG is used for translation
initiation, since this start site is absent in Lelystad virus.
In addition, a search of GenBank identified at least two
other North American strains containing ORF2 se-
quences lacking the second ORF2b start site (Fig. 3A).
Western blots of insect cells infected with AcVR2, a
recombinant baculovirus clone containing the 771-bp
FIG. 2. Appearance of the 10-kDa protein during PRRSV infection of
MARC-145 cells. MARC-145 cells were infected with SDSU-23983 at an
m.o.i. of approximately 0.1 TCID50/cell. At different times after infection
the cells were harvested, proteins electrophoresed, and PRRSV pro-
teins identified by immunoblotting using pooled immune pig sera.
Molecular size markers, in kDa, are indicated on the left. Arrow iden-
tifies the location of the 10-kDa virion-associated protein identified in
Fig. 1.
FIG. 3. Amino acid sequences of ORF2b proteins from North Americ
SDSU-23983, Lelystad, and two Taiwan isolates that belong to the Nort
Comparison of translated 2b open reading frames from SDSU-23983 a
amino acid changes are indicated with vertical lines. Conserved myris
indicated by single and double asterisks, respectively.full-length ORF2 cDNA, revealed the presence of a 10-
kDa protein that reacted with PRRSV immune pig sera
(Fig. 4, lane 2 arrow). This protein was much smaller in
size than the predicted 24-kDa GP2 product and corre-
sponded to the predicted size of the ORF2b product.
Baculovirus clones that contained only the ORF2b coding
region expressed a 10-kDa protein. Recombinant 2b was
not detected in lysates from control virus (AcMNPV)-
infected insect cells (Fig. 5) or in Western blots of AcVR2-
infected cells incubated with sera from PRRSV antibody-
negative pigs (Table 1). The baculovirus expression ex-
periments frequently revealed the 2b product as a diffuse
band or a doublet (Fig. 4, lane 2 arrow). The presence of
2b as a heterogeneous protein was not unexpected,
since a similar observation was reported for recombi-
nant EAV E protein produced in BHK cells (Snijder et al.,
European PRRSV. (A) Locations of ORF2a and ORF2b start codons of
ican genotype (GenBank Accession Nos. AF121131 and AF035409). (B)
stad virus (Snijder et al., 1999) was made using CLUSTAL. Conserved
n and CK-II phosphorylation sites were identified using PROSITE and
FIG. 4. Baculovirus expression of ORF2b and antigenic identity with
the 10-kDa PRRSV protein. Western blots of sucrose gradient-purified
PRRSV SDSU-23983 (lanes 1 and 3) and AcVR2 baculovirus expressing
a 10-kDa recombinant ORF2b protein (lanes 2 and 4). Pooled immune
pig sera for the identification of PRRSV proteins were preadsorbed with
control AcMNPV (lanes 1 and 2) or AcVR2 cell lysates (lanes 3 and 4)
prior to incubation with membranes.an and
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186 WU ET AL.1999). The nature of this heterogeneity is not known but
may represent differences in gel migration that result
from posttranslational modifications.
The antigenic similarities between recombinant 2b
and the 10-kDa virus-associated protein were studied by
probing Western blots with immune pig sera pread-
sorbed with a lysate from 2b-expressing insect cells. A
representative result, presented in Figs. 4 and 5, showed
loss of immune reactivity to both recombinant 2b and
viral 10-kDa proteins when sera were adsorbed with the
AcVR2 cell lysates prior to immunostaining (Fig. 4, lane 3
and 4, and Fig. 5B, lanes V and 2). Treatment of immune
pig sera with AcVR2 did not affect the recognition of the
other major PRRSV structural proteins (Figs. 4 and 5) or
baculovirus-expressed recombinant M, N, and GP5 pro-
teins (Fig. 5). These results demonstrate that 2b and the
10-kDa protein are immunologically similar.
The presence of anti-2b activity in pooled immune sera
FIG. 5. Baculovirus expression of recombinant PRRSV structural
proteins. Proteins prepared from sucrose gradient-purified PRRSV
SDSU-23983 (V) and cell lysates of baculovirus clones AcVR2 (ORF2,
lane 2), AcVR5 (ORF5, GP5, lane 3), AcVR6 (ORF6, M, lane 4), AcVR7
(ORF7, N, lane 5), and AcMNPV (no PRRSV protein, lane 6) were
electrophoresed and immunoblotted with pooled immune pig sera
preincubated with AcMNPV (A) or AcVR2 cell lysates (B). Arrows iden-
tify the location of the recombinant 2b protein. Lane 1 contains proteins
from uninfected MARC-145 cells.
T
The Appearance of ORF2b Protein Antibodies during Inf
Pig No.
Day 0 Day 7 Day 11 Day 14 Day 18
Tb 2bc T 2b T 2b T 2b T 2b
71-4 0.12 2 0.16 2 0.84 2 1.21 2 1.41 2
71-5 0.12 2 0.31 2 0.89 2 1.29 2 1.38 2
71-9 0.01 2 0.16 2 0.77 2 1.14 2 1.40 2
291-4 0.04 NT 0.00 2 0.44 2 0.74 2 0.88 2
291-6 0.12 2 0.15 2 0.32 2 0.42 2 0.56 2
291-7 0.30 2 0.33 2 0.80 2 0.77 2 0.79 2
68-9 0.02 2 0.15 2 0.71 2 1.09 2 1.26 2
68-10 0.04 2 0.06 2 0.85 2 1.19 2 1.54 1
Note. NT, not tested.
a Eight adult boars were infected with SDSU-23983 and sera assess
b T, total antibody was measured using the commercial IDEXX ELIS
c 2b, the presence (1) or absence (2) of anti-2b antibody as determ
d N, virus neutralization of sera was as described under Materials and Methsuggested that 2b-specific antibodies were produced in
pigs in response to PRRSV infection. Immunoblots con-
taining recombinant 2b were used to identify the pres-
ence of anti-2b antibodies in sera samples from eight
experimentally infected boars (Table 1). Total PRRSV
antibody, detected by the IDEXX HerdCheck PRRS ELISA,
appeared in all pigs by 14 days after infection and at-
tained peak levels between 25 and 39 days after infec-
tion. Almost all boars developed detectable levels of
virus neutralizing activity, which first appeared at 25 days
after infection. Neutralizing titers ranged between 1:4
and 1:16 (Table 1). This low amount of neutralizing activ-
ity is typical of PRRSV infection (Yoon et al., 1994; Yoon et
al., 1995; Rowland et al., 1999b). Antibodies specific for
recombinant 2b protein appeared by 18 days after infec-
tion, and by 39 days all pigs were 2b-positive. Anti-2b
antibodies were not detected in preinfection serum sam-
ples (Table 1) (n 5 8).
As indicated earlier, the AcVR2 clone used for the
study of the 2b protein contained the entire 771-bp ORF2
cDNA, including the ORF2a start codon. Preparation of
recombinant baculoviruses containing only ORF2b ex-
pressed the same 10-kDa protein with identical immu-
nological properties (data not shown). Overexposed films
of 35S-labeled proteins from AcVR2 lysates immunopre-
ipitated with pooled immune pig sera revealed the pres-
nce of a minor 24- to 25-kDa protein, which is the
redicted size of GP2 (data not shown). A similar protein
as also detected by Western immunoblotting of whole-
ell lysates but with higher background. GP2 was also
xpressed as a GST fusion protein, resulting in the de-
ection of a 50-kDa protein (data not shown), which is the
redicted size of the unprocessed GP2 (Murtaugh et al.,
995; Bautista et al., 1999) plus the 25-kDa GST protein.
owever, due to the similarities in size between GP2 and
of Adult Boars with the SDSU-23983a Isolate of PRRSV
21 Day 25 Day 35 Day 39 Day 46
2b T Nd 2b T 2b T N 2b T N 2b
2 1.60 4 2 1.99 1 1.68 4 1 1.34 16 1
2 1.30 0 2 1.80 2 1.51 0 1 NT NT NT
2 1.59 0 1 1.62 1 1.39 8 1 1.3 16 1
2 1.29 0 1 1.26 1 1.18 4 1 NT NT NT
2 1.02 0 2 1.09 2 1.93 0 1 1.05 16 1
2 0.82 4 1 0.99 1 0.80 4 1 0.86 16 1
2 1.44 0 1 1.91 1 1.55 4 1 1.59 16 1
1 1.59 0 1 1.87 1 1.74 8 1 1.58 16 1
total antibody, virus neutralizing activity, and anti-2b antibody.
esults are reported as SP ratio (positive 5 SP ratio $0.4).
y immunoblots containing recombinant 2b protein.ABLE 1
ection
Day
T
1.45
1.42
1.40
0.96
0.69
0.74
1.35
1.59
ed for
A and r
ined b
ods and results are reported as the inverse of the neutralization titer.
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187ORF2b PROTEIN OF PRRSVGP5 and the unavailability of GP2-specific sera against
North American PRRSV isolates, we were not able to
identify the presence of GP2 in virions.
The results from the AcVR2 construct suggested that
the 2b protein was the principal product of ORF2. We
investigated the relative translation efficiencies from the
TABLE 2
Relative Expression Levels Following Transfection of MARC-145
Cells with ORF2a and ORF2b EGFP Fusion Constructs
EGFP
construct ORF
Expression
level ORF2 sequencea
1.2a 2ab (1/2)c
O¡
11
•
ATGAA
16
•
ATGGGGTCC
115
•
ATGC. . .768
1.2b 2b (1111) O¡
ATGGGGTCCATGC. . .224
2.2b 2b (1111)
ATGAAA
O¡
TGGGGTCCATGC. . .224
2.2a 2a (11)
A
¡
TGAAATTGGGTCCTTGC. . .768
3.2b 2b (1111)
226. . .ATGAAA
O¡
TGGGGTCCATGC. . .224
3.2a 2a (1/2)
226. . .A
¡
TGAAATGGGGTCCATGC. . .768
4.2a 2a (1/2)
226. . .A
O¡
TGAAATGGGGTCCATGC. . .225
5.2a 2a (1)
226. . .A
¡
TGGAATGGGGTCCATGC. . .768
a The 59 sequence and total length of ORF2 ligated into the
pEGFP-N1 cloning vector. The arrow identifies the first ATG that is in
the same reading frame as EGFP.
b The ORF placed in the same reading frame as the EGFP gene.
c The relative expression of each construct was determined after
transfection with a range of DNA concentrations. The results identify
the DNA concentration that produced the maximum number of fluores-
cent cells. The data reflect representative results for three independent
experiments. Key: (1111) greater than 50% of cells showing fluores-
cence with a predominance of bright cells, (111) 30–40% fluorescent
cells with many bright cells, (11) 20–30% fluorescent cells with only a
few bright cells, (1) 10–20% fluorescent cells with no bright cells, (1/2)
only a few faint fluorescent cells visible in a single well of a six-well
plate. Representative photomicrographs of bright and faint fluorescent
cells are shown in Figs. 6A and 6B, respectively.
FIG. 6. Expression of ORF2–EGFP fusion proteins in MARC-145 cells.
with pEGFP (A), pEGFP-ORF2a (B), or pEGFP-ORF2b (C) constructs. The
with constructs 1.2a and 1.2b in Table 2, respectively. Key: Nu, nucleus; No, nORF2a and 2b start codons by expressing ORF2 con-
structs fused with an enhanced green fluorescent pro-
tein (EGFP) tag, which was placed in either the ORF2a or
the ORF2b reading frame. Placing the EGFP gene in the
same reading frame as ORF2a produced only a few
fluorescent cells that were very faint, which indicated a
low amount of expression (see construct 1.2a in Table 2
and Fig. 6B). In contrast, transfection with ORF2–EGFP
constructs placed in the ORF2b reading frame consis-
tently produced cultures that contained greater than 50%
fluorescent cells, including a large number of bright cells
(see constructs 1.2b, 2.2b, and 3.2b, Table 2 and Fig. 6C).
Constructs possessing both 2a and 2b start codons
preferentially produced larger amounts of EGFP protein
when the EGFP gene was placed in the same reading
frame as the 2b AUG (compare construct 1.2a with con-
struct 2.2b and construct 3.2b and 4.2a with construct
3.2b in Table 2). EGFP is normally distributed throughout
the cell, localizing to both cytoplasmic and nuclear com-
partments (Rowland et al., 1999a; Fig. 6A). In contrast, the
pattern of EGFP fluorescence in the 2b constructs was
predominately perinuclear, similar to the pattern reported
for the EAV E protein (Fig. 6C; Snijder et al., 1999). The
ellular distribution of 2a–EGFP was also cytoplasmic
Fig. 6B). Constructs 1.2a, 1.2b, and 2.2b, as well as the
aculovirus construct AcVR2, contained vector sequence
mmediately upstream of the 2a start site, which may
ave influenced translation from the 2a or 2b start
odons. Including the 26 nucleotides preceding ORF2a,
hich encompassed the region from the end of the
eader to the 2a start codon, produced no apparent
hange in ORF2a or 2b protein expression (see con-
tructs 3.2a and 3.2b, Table 2). Furthermore, truncating
he 2a construct to the same length as 2b also failed to
mprove translation from the 2a start site. Therefore, in
ur experimental system the length of the construct or
ddition of the 26 upstream nucleotides did not affect the
fficiency of translation from 2a or 2b start codons. How-
ver, 2a–EGFP expression was improved following the
emoval of both potential 2b start codons (see construct
.2a in Table 2).
icrographs of EGFP fluorescence in MARC-145 cells after transfection
d 2b results are representative of cells observed following transfectionPhotom
2a anucleolus.
2
O
188 WU ET AL.The optimal sequence for translation that surrounds a
potential codon was determined by Kozak (1986) to be
CC(A/G)CCAUGG (the start codon is underlined and the
A in AUG is position 11). The most important nucleotides
are the A/G at position 23 and the G at 14. The nucle-
otide sequences surrounding the AUG of 2a and 2b
ORFs are nearly identical (UUGAAAUGA for 2a and AU-
GAAAUGG for 2b), with the exception of a U in 2a versus
an A for 2b at position 25 and a G in the 14 position of
b versus A in 2a (see Fig. 3A). We attempted to improve
RF2a expression by replacing the A with a G in the 14
position of the 2a start codon, thus placing the 2a start
codon in better context for initiation of translation. The
results showed an increase in 2a expression relative to
the wild-type 2a construct (compare constructs 5.2a and
3.2a in Table 2); however, 2a expression never reached
the level we observed for the 2b constructs. We recog-
nized that differences in EGFP expression could have
resulted from differences in the transfection efficiencies
of individual constructs. We cannot entirely rule out this
possibility; however, each transfection experiment incor-
porated a broad range of DNA concentrations. Therefore,
the results for each construct in Table 2 reflect the
quantity and quality of fluorescence that was obtained
using the DNA concentration that gave the maximum
number of fluorescent cells. Also, each transfection ex-
periment was repeated at least three times.
The results from this study identify a 10-kDa structural
protein in PRRSV produced by ORF2b. Furthermore, the
presence of 2b-specific antibody in the sera from in-
fected pigs demonstrates that this protein is naturally
produced during infection and is not an artifact of cell
culture. The gene that codes for the 2b protein is com-
pletely embedded within the much larger ORF2a. There-
fore, ORF2 codes for two proteins, the 2b protein and the
much larger GP2. Expression of ORF2 cDNA in baculo-
virus and in MARC-145 cells confirms that the 2b protein
is the predominate product of ORF2. However, some
initiation does occur at the upstream 2a AUG, which is
consistent with relatively small amounts of GP2 present
in infected cells and whole virions (Meulenberg et al.,
1995; Meulenberg and Peterson-den Besten, 1996). The
ORF2a and 2b start codons are separated by only 2
nucleotides. The bicistronic expression of genes con-
taining two start codons in close proximity is not un-
usual. Williams and Lamb (1989) described the produc-
tion of influenza B NA and NB proteins from a gene in
which the two start codons were separated by four nu-
cleotides. Kozak (1995) reported the preferential use of a
second codon containing the sequence AUGACAUGG
(the first and second start codons are underlined). The
placement of a G in the 14 position of the first codon,
producing the sequence AUGGCAUGG, switched trans-
lation to the first codon. We found that placing a G after
the 2a start codon increased the expression of the EGFP
fusion protein placed in the same reading frame asORF2a. Therefore, we propose that the regulation of
translation from the 2a and 2b start sites is at least
partially determined by a Kozak-like sequence. However,
our efforts to improve translation from the 2a start codon
by inserting upstream nucleotides and by placing the 2a
AUG in a more favorable context for translation did not
enhance the translation of the 2a protein. One possibility
is that nucleotide sequences downstream of the ORF2
start codons influence translation (Kozak, 1995).
The results from this study and the work of others (Dea
et al., 2000) suggest that the PRRS virion is composed of
up to seven structural proteins, which include GP5, M, N,
and 2b as major structural components and GP2, GP3,
and GP4 as possible minor components. The results
suggest that the 2b protein is the principal product of
ORF2. The presence of relatively large amounts of 2b in
the virion, combined with a high degree of conservation
between European and North American isolates, raises
the possibility that this protein may be an integral com-
ponent of the virion and perhaps useful in the diagnosis
of PRRSV infection.
MATERIALS AND METHODS
Virus and cells
SDSU-23983 P6, a wild-type PRRSV isolate, was grown
on MARC-145 cells, a subclone of the monkey kidney cell
line, MA104 (Kim et al., 1993). MARC-145 cells were
maintained in Eagle’s minimal essential medium (MEM)
supplemented with 10% fetal bovine serum. Cultures
were infected at an m.o.i. of 0.1 TCID50/cell. Recombinant
baculoviruses were derived from the parent strain, AcM-
NPV, and propagated in Sf-9 cells derived from Spodopt-
era frugiperda maintained in Sf-900II serum-free medium
(SFM) (Gibco BRL, Gaithersburg, MD). High-Five insect
cells maintained in High-Five medium (Invitrogen, Carls-
bad, CA) were used for the study of protein expression.
Virus purification
Sucrose gradient purification of PRRSV was according
to Benfield et al. (1992) and Bautista et al. (1996) using a
modification of the procedure originally described by
Brinton-Darnell and Plagemann (1975) for the isolation of
LDV. Medium from infected or mock-infected MARC-145
cells was loaded onto a 0.5 M sucrose cushion and
centrifuged at 25,000 rpm in an SW40 Beckman rotor for
5 h. Pellets were resuspended in TNE buffer (100 mM
NaCl, 1 mM EDTA, 10 mM Tris–HCl, pH 7.5), freon ex-
tracted, and then loaded onto a 0.5 to 1.5 M continuous
sucrose gradient and centrifuged at 33,000 rpm for 12–15
h at 4°C using an SW40 rotor (Beckman). Sucrose con-
centration of gradient fractions for the determination of
density was measured with a refractometer. Fractions
were diluted 10-fold in TNE buffer, then centrifuged at
33,000 rpm in an SW40 rotor (Beckman) for 2 h. Pellets
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189ORF2b PROTEIN OF PRRSVwere dissolved in Laemmli sample buffer (50 mM Tris–
HCl, pH 6.8, 1% SDS, 1% 2-mercaptoethanol, 0.1% brom-
phenol blue; Laemmli, 1970) for electrophoresis and im-
munoblotting.
Measurements of total antibody and virus
neutralization activity
PRRSV antibody levels in serum were measured using
the IDEXX HerdCheck PRRS ELISA. A sample to positive
(S/P) ratio of 0.40 or greater was considered seroposi-
tive. PRRSV neutralizing activity in serum was measured
using a modified fluorescent focus neutralization assay.
Dilutions of pig serum were prepared on 96-well plates
in MEM supplemented with 2% horse serum. An equal
volume of the homologous virus, at a concentration of
2000 TCID50/ml, was added to each sample and incu-
ated for 1 h at 37°C, then transferred to a 96-well plate
ontaining confluent MARC-145 cells. After 24 h, the
lates were fixed in 80% acetone and infected cells
etected following a 1-h incubation with fluorescein-
onjugated anti-PRRSV monoclonal antibody, SDOW-17,
iluted 1:100 in PBS with 5% horse serum. Neutralizing
ctivity was reported as the last dilution that showed a
0% or greater reduction in the number of fluorescent
oci.
estern blot identification of viral proteins
Cellular and viral proteins were resolved by SDS–
AGE on a 17% acrylamide gel, then transferred to nitro-
ellulose membranes (Schleicher & Schuell, Keene, NH).
embranes were blocked in PBS containing 0.5% (v/w)
ween 20 (PBST) for 45 min at room temperature. Mem-
ranes were either incubated with a 1:1000 dilution of
nti-glutathione-S-transferase (GST) monoclonal anti-
odies (Clontech Laboratories, Palo Alto, CA) or a 1:100
ilution of pooled PRRSV immune pig sera diluted in
BST and incubated 45 min at room temperature. Pooled
RRSV pig sera were selected from naturally infected
igs having a high commercial ELISA titer (IDEXX Herd-
heck PRRS; IDEXX Laboratories, Westbrook, ME) which
ecognized recombinant GP5 in the Western blot assay.
era from experimentally infected animals were ob-
ained from a previous study (Christopher-Hennings et
l., 2001). Bound mouse or pig antibodies were detected
ith protein G horseradish peroxidase (Sigma, St. Louis,
O), diluted to 0.2 mg/ml in PBST. After three washes in
BST, peroxidase activity was detected using SuperSig-
al West Pico chemiluminescence substrate (Pierce
hemical, Rockford, IL) according to the manufacturer’s
nstructions and filter membranes were exposed to
odak X-OMAT X-ray film.
aculovirus expression of viral proteins
PRRSV ORF 2a, 2b, 5, 6, and 7 cDNAs were obtained
y RT-PCR amplification of total RNA from SDSU-23983-nfected MARC-145 cells while GST cDNA was from the
ector pGEX-4T3 (Amersham Pharmacia Biotech, Pisca-
away, NJ). Amplification was performed using the for-
ard and reverse PCR primers listed in Table 3. PCR
roducts were cloned, sequenced, and then ligated
ownstream of the polyhedrin promoter of the baculovi-
us transfer plasmid pFASTBacDual or pFASTBacHTc
Gibco BRL). In order to express the GST–ORF2 fusion
rotein, GST cDNA was inserted upstream of the ORF2
nd replaced the RsrII–EcoRI 63histidine fragment of
he recombinant vector pFASTBacHTc-ORF2. Recombi-
ant baculoviruses were constructed by transposition
nto AcMNPV according to the manufacturer’s instruc-
ions (“Bac to Bac” manual; Gibco BRL).
adioimmunoprecipitation
Half-confluent High-Five insect cells in 100-mm culture
ishes were infected at 10 m.o.i. for 72 h in High-Five
edium and then washed two times with 10 ml of me-
hionine/cysteine-free Sf900II SFM (Gibco BRL), followed
y starving for 1 h in 10 ml of the same medium. Infected
ells were then metabolically labeled for 10 h with
35S]methionine/cysteine (ICN Pharmaceuticals, Irvine,
A), at 20 mCi/ml in 8 ml of methionine/cysteine-free
Sf900II SFM. After labeling, insect cells were collected,
washed twice in 10 ml of STE buffer (150 mM NaCl, 1 mM
EDTA, pH 8.0, and 10 mM Tris–HCl), and lysed in 2 ml of
RIPA buffer (0.5% (w/v) sodium deoxycholate, 1% (w/v)
SDS, and 1% (v/w) NP-40 in TNE buffer (100 mM NaCl, 1
mM EDTA, pH 8.0, 10 mM Tris–HCl, pH 7.5)) supple-
mented with a protease inhibitor cocktail tablet (Com-
plete Mini EDTA-Free tablet; Roche Biochemicals, India-
napolis, IN) (one tablet in 10 ml of RIPA buffer) (Roche
Biochemicals) at 4°C for 5 min. The cell lysates were
centrifuged at 6000g for 15 min and the supernatant was
diluted 10-fold in RIP buffer (0.5% (w/v) sodium deoxy-
cholate and 1% (v/w) NP-40 in TNE buffer). One milliliter
of the diluted cell lysate was immunoprecipitated with 10
TABLE 3
Primer Sequences Used for the PCR Amplification of ORFs
from PRRSV Isolate SDSU-23983
Primer Sequence
ORF2a forward 59 ATGAAATGGGGTCCATGCAAAGCCT 39
ORF2a reverse 59 CTGCAGTCACCGTGAGCTCGAAGGAAAAGTTGC 39
ORF2b forward 59 ATAGGATCCATGGGGTCCATGCAAAGCCTTTTT 39
ORF2b reverse 59 CCGCTCGAGTCATAAGATCTTCTGTAATTGCTC 39
ORF5 forward 59 ATGTTGGGGAAATGCTTGACCGC 39
ORF5 reverse 59 CTGCAGCTAAGGACGACCCCATTGTTCCG 39
ORF6 forward 59 ATGGGGTCGTCCTTAGATGACTTT 39
ORF6 reverse 59 CTGCAGTTATTTGGCATATTTGACAAGGTTT 39
ORF7 forward 59 GGATCCAATATGCCAAATAACAACGGC 39
ORF7 reverse 59 TCATGCTGAGGGTGATGCTGTGA 39
GST forward 59 GTCGGTCCGTCATGTCCCCTATACTAGGTTATTGG 39
GST reverse 59 CTCGAGTCGACCCGGGAATTCGGGGATCCACGC 39ml of anti-PRRSV pig antiserum at 4°C for 1 h. Fifty
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190 WU ET AL.microliters of a 50% suspension of protein A–Sepharose,
CL-4B (Amersham Pharmacia Biotech, Piscataway, NJ)
was added to the cell lysate/antibody mixture and incu-
bated at 4°C for 16 h. The immune complexes adsorbed
on the Sepharose CL-4B beads were washed six times
at room temperature with RIP buffer and 1 time in TNE
buffer and boiled in Laemmli sample buffer for 17% SDS–
polyacrylamide gel electrophoresis. Dried gels were
then exposed to Kodak X-OMAT X-ray film.
Preparation of ORF2–EGFP fusion constructs
The preparation and transfection of ORF2–EGFP ex-
pression constructs was performed according to Row-
land et al. (1999a). PCR was used to add EcoRI and SacII
restriction sites to the 59 and 39 ends of each ORF2
construct, respectively. PCR products were double-di-
gested with the appropriate restriction enzymes and then
ligated into the multiple cloning site of pEGFP-N1 (Clon-
tech). Transfection of pEGFP constructs into MARC-145
cells was performed using Lipofectamine (Gibco BRL)
and carried out on six-well plates according to the man-
ufacturer’s directions. After 18–24 h, cultures were
viewed under a fluorescence microscope (Olympus Op-
tical) equipped with a standard FITC excitation filter.
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